Oxoid Antimicrobial Susceptibility Test Discs, Cefpodoxime 10 mcg., CT1612B, packaged in cartridg...

FDA Device Recall #Z-0792-2014 — Class II — April 9, 2013

Recall Summary

Recall Number Z-0792-2014
Classification Class II — Moderate risk
Date Initiated April 9, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Remel Inc
Location Lenexa, KS
Product Type Devices
Quantity 9 packs

Product Description

Oxoid Antimicrobial Susceptibility Test Discs, Cefpodoxime 10 mcg., CT1612B, packaged in cartridges of 50 discs, 5 cartridges/pack. The firm name on the label is Oxoid Ltd., Basingstoke, Hampshire, England. Used in the semi-quantitative agar diffusion test method for in-vitro susceptibility testing to assist in the determination of a suitable antibiotic agent for treatment purposes

Reason for Recall

Cartridges may contain individual discs which were not impregnated with antibiotic.

Distribution Pattern

Nationwide Distribution: US including Puerto Rico.

Lot / Code Information

Lot 1275353, Exp. 31Dec2015

Other Recalls from Remel Inc

Recall # Classification Product Date
Z-0331-2023 Class I Thermo SCIENTIFIC, Sensititre CMC5VGNF, Gram Ne... Oct 20, 2022
Z-0334-2023 Class I Thermo SCIENTIFIC, Sensititre STP6F, Gram Negat... Oct 20, 2022
Z-0330-2023 Class I Thermo SCIENTIFIC, Sensititre HPB1, Gram Negati... Oct 20, 2022
Z-0329-2023 Class I Thermo SCIENTIFIC, Sensititre GN7F, Gram Negati... Oct 20, 2022
Z-0327-2023 Class I Thermo SCIENTIFIC Sensititre Plate, GN4F, Gram ... Oct 20, 2022

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.